Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-001347
Filing Date
2017-02-10
Accepted
2017-02-10 06:04:03
Documents
75
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvet-10q_20161231.htm 10-Q 1830482
2 EX-12.1 nvet-ex121_9.htm EX-12.1 146503
3 EX-31.1 nvet-ex311_10.htm EX-31.1 10557
4 EX-31.2 nvet-ex312_7.htm EX-31.2 10246
5 EX-32.1 nvet-ex321_6.htm EX-32.1 7620
6 EX-32.2 nvet-ex322_8.htm EX-32.2 7621
  Complete submission text file 0001564590-17-001347.txt   7696398

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvet-20161231.xml EX-101.INS 1894863
8 XBRL TAXONOMY EXTENSION SCHEMA nvet-20161231.xsd EX-101.SCH 54806
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvet-20161231_cal.xml EX-101.CAL 42982
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvet-20161231_def.xml EX-101.DEF 146868
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvet-20161231_lab.xml EX-101.LAB 371769
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvet-20161231_pre.xml EX-101.PRE 297440
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36828 | Film No.: 17589366
SIC: 2834 Pharmaceutical Preparations